skip navigation


Home » Resources » Clinical Studies » An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia

Clinical Studies Supported by the NEI

An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia

Purpose | Background | Description | Patient Eligibility | Patient Recruitment Status | Current Status of Study | Results | Publications | Clinical Centers | NEI Representative | Resource Centers

Purpose:

  • To estimate the duration of misalignment by age at presentation in infantile esotropia (infantile ET), acquired non-accommodative esotropia (ANAET) and acquired partially accommodative esotropia (APAET).
  • To determine the proportion of patients with angle instability in infantile ET, ANAET and APAET by length of follow-up.

Background:

Approximately one third of infants with infantile esotropia (infantile ET) and a similar proportion of children with acquired non-accommodative esotropia (ANAET) will have an increasing angle within the first few months of their initial examination. In approximately two thirds of patients, the angle of misalignment remains stable and in a small proportion, the angle of esotropia decreases. The changing angle of misalignment in a significant proportion of children with esotropia raises an important question regarding the timing of surgical management of these children: should surgery be undertaken immediately or delayed until the alignment stabilizes? Early surgery may improve sensory outcomes; delayed surgery may improve surgical dosing accuracy and motor outcomes.

Children with acquired partially accommodative esotropia (APAET) may differ from those with infantile ET and ANAET in that they tend to present at an older age, are more likely to preserve high-grade stereopsis with appropriate treatment, require surgical intervention less frequently, and have more substantial hyperopic refractive errors. Little is known regarding early angle stability in this group of patients following correction of their refractive errors.

Although there is a need for a randomized trial to address the issue of timing of surgery in infantile ET, APAET, and ANAET, prior to designing such a trial, high-quality preliminary data are needed. We propose a multi-center observational study to 1) determine the duration of misalignment in infantile ET, ANAET, and APAET at study enrollment, 2) to prospectively establish the proportion of patients with angle instability in infantile ET, ANAET, and APAET, and 3) to determine recruitment potential for a randomized trial. These data will be crucial for sample size calculations for the eventual randomized trial, and will help further define the clinical characteristics of these conditions.

A concurrent and nested ancillary study will be conducted at selected centers to collect test-retest data on alignment measurements for estimating the amount of measurement variability. These test-retest data will be used to define a change in angle alignment that exceeds an amount which could reasonably be due to measurement error, which will be used in evaluating the proportion of patients with angle instability in the current study.

Description:

Eligible patients with infantile ET will be consented and enrolled at their initial visit. Infantile ET patients who need spectacles will be prescribed spectacles and will return for an Infantile ET Spectacle Baseline Visit 2 weeks later.

ANAET and APAET patients who present wearing spectacles with appropriate correction for at least 2 weeks will be consented and enrolled into the study at that initial visit.

For ANAET and APAET patients who present not wearing spectacles:
  • Patients who do not need spectacles will be consented and enrolled into the study at that initial visit.
  • Patients who need spectacles are prescribed appropriate correction if the investigator intends to offer the patient enrollment at a later date. Patients are asked to return after wearing the new spectacles 2-6 weeks, at which time they may be consented and enrolled into the study.

Sample Size: The study will enroll 100 patients for each of the three esotropia types of infantile ET, ANAET, and APAET, for a total of 300 patients.

Patient Eligibility:

1. Age at enrollment:
a) For infantile ET: less than 12 months old
b) For ANAET or APAET: 6 months to <5 years old
2. Duration of esotropia less than 6 months by best estimate (photos, parent history, physician records)
3. A constant or variable* esotropia meeting the following criteria:
For infantile ET:
a) Onset before six months of age
b) Measuring >10 PD by Alternate Prism and Cover Test (APCT) in the primary position at distance fixation on an accommodative target
For ANAET:
a) Onset after six months of age
b) Angle decreases less than 10 prism diopters (PD) by Alternate Prism and Cover Test (APCT) in the primary position at distance fixation with correction
c) Residual angle measures >10 PD by Simultaneous Prism and Cover Test (SPCT) in the primary position at distance fixation
For APAET:
a) Onset after six months of age
b) Angle decreases 10 prism diopters (PD) or more by Alternate Prism and Cover Test (APCT) in the primary position at distance fixation with correction
c) Residual angle measures >10 PD by Simultaneous Prism and Cover Test (SPCT) in the primary position at distance fixation
*The deviation can be variable if the minimum angle meets the above criteria, however, a patient whose deviation is intermittent on any measurement is ineligible.
4. Spectacle correction history
a) For infantile ET: no prior spectacle wear
b) APAET or ANAET:
i) For patients who have significant refractive error, full hyperopic correction determined with cycloplegia must have been worn for at least 2 weeks.
ii) For patients who do not have significant refractive error, whether to prescribe spectacles is at investigator discretion, however, if the investigator elects to prescribe spectacles, the full hyperopic correction determined with cycloplegia must have been worn for at least 2 weeks.
5. Gestational age > 34 weeks
6. Birth weight > 1500 grams
7. No atropine use within the last two weeks
8. No history of CNS disease (e.g. intraventricular hemorrhage (IVH), periventricular leukomalasia (PVL), meningitis, developmental abnormalities of the brain, hydrocephalus, cerebral palsy, hypoxic ischemic encephalopathy)
9. No significant developmental delay in the investigator’s judgment (isolated speech delay excepted)
10. No limitation of abduction consistent with paralytic or restrictive myopathy (minor limitation of abduction due to cross fixation is acceptable)
11. No craniofacial malformation affecting the orbits
12. No prior extraocular muscle surgery or intraocular surgery
13. No structural ocular abnormalities (e.g. media opacity, optic atrophy, optic nerve hypoplasia, retinal detachment)

Patient Recruitment Status:

No longer recruiting. Comments: Recruitment started June 2004 and ended May 31, 2007 with 293 patients enrolled.

Current Status of Study:

Ongoing. Comments:

Results:

None

Publications

None

Clinical Centers


Alaska
Robert W. Arnold, M.D.
Ophthalmic Associates
542 W. 2nd Avenue
Anchorage, AK 99501-2242
USA

Connecticut
Andrew J. Levada, M.D.
Eye Care Group, PC
1201 W Main St.
STE 100
Waterbury, CT 06708
USA

Connecticut
Darron A. Bacal, M.D.
Eye Physicians & Surgeons, PC
Medical Center of Orange
202 Cherry Street
Milford, CT 06460
USA

Idaho
Katherine A. Lee, M.D., Ph.D.
Private Practice
100 E. Idaho St.
Suite 311
Boise, ID 83712
USA

Illinois
Deborah R. Fishman, M.D., Lisa C. Verderber, M.D.
Pediatric Eye Associates
3612 Lake Avenue
Unit 3
Wilmette, IL 60091-1000
USA

Indiana
Derek T. Sprunger, M.D.
Midwest Eye Institute
702 Rotary Circle
Indianapolis, IN 46202
USA

Iowa
Donny W. Suh, M.D.
Wolfe Clinic
6200 West Town Parkway
West Des Moines, IA 50266
USA

Massachusetts
Daniel M. Laby, M.D.
Private Practice
1 Tamarack Way
Sharon, MA 02067
USA
Telephone: (781) 769-4797

Massachusetts
John P. Donahue, M.D., Ph.D.
Center for Eye Health Truesdale Clinic
1030 President Ave
Fall River, MA 02720
USA

Minnesota
C.Gail Summers, M.D., Stephen P. Christiansen, M.D., Erick D. Bothun, M.D.
University of Minnesota
Dept. of Ophthalmology
420 Delaware Street SE
Mayo Mail Code 493
Minneapolis, MN 55455-0501
USA

Minnesota
Jonathan M. Holmes, M.D., Brian G. Mohney, M.D.
Mayo Clinic
Dept. of Ophthalmology W7
200 1st Street SW
Rochester, MN 55905-0002
USA

Missouri
Oscar A. Cruz, M.D., Bradley V. Davitt, M.D.
Cardinal Glennon Children's Hospital
1755 S. Grand Blvd.
St. Louis, MO 63104-1095
USA

New Mexico
Todd A. Goldblum, M.D.
Goldblum Family Eye Care Center, P.C.
303 Mulberry NE
Suite D
Albuquerque, NM 87106
USA

North Carolina
David K.Wallace, M.D.
UNC Department of Ophthalmology
5105 Bioinformatics, CB# 7040
130 Mason Farm Rd.
Chapel Hill, NC 27599-7040
USA

Oklahoma
Lucas A. Trigler, M.D., R. Michael Siatkowski, M.D.
Dean A. McGee Eye Institute
University of Oklahoma
608 Stanton L. Young Blvd.
Oklahoma City, OK 73104
USA

Pennsylvania
Darren L. Hoover, M.D.
Everett and Hurite Ophthalmic Association
Mercy Hospital
Room 3103, Building D
1400 Locust Street
Pittsburgh, PA 15129
USA

Pennsylvania
David I. Silbert, M.D., Eric L. Singman, M.D., Ph.D.
Family Eye Group
2110 Harrisburg Pike
Suite 215
Lancaster, PA 17601
USA

Pennsylvania
Nicholas A. Sala, D.O.
Pediatric Ophthalmology of Erie
2201 W. 38th Street
Erie, PA 16506-4501
USA

Rhode Island
John P. Donahue, M.D.
Rhode Island Eye Institute
150 East Manning Street
Providence, RI 02906
USA

Tennessee
Robert W. Enzenauer, M.D.
Pomerance Eye Center, PC
CBL Center, Suite 140
2030 Hamilton Place Blvd.
Chattanooga, TN 37421-6039
USA

Texas
David R. Stager Sr., M.D., Priscilla M. Berry, M.D.
Pediatric Ophthalmology, P.A.
8201 Preston Rd.
Suite 140A
Dallas, TX 75225
USA

Texas
Kimberly G. Yen, M.D.
Texas Children's Hospital
6621 Fannin St. MC3-2700
Houston, TX 77030-2399
USA

Virginia
Earl R. Crouch Jr., M.D.
Eastern Virginia Medical School
Department of Ophthalmology
880 Kempsville Rd.
STE 2500
Norfolk, VA 23502-3942
USA

West Virginia
Deborah L. Klimek, M.D.
Children's Eye Care & Adult Strabismus Surgery
24 MacCorkle Avenue SW
Suite 203
South Charleston, WV 25303
USA

NEI Representative



Donald F. Everett, M.A.
National Eye Institute
National Institutes of Health
Suite 1300
5635 Fishers Lane MSC 9300
Bethesda, MD 20892-9300
USA
Telephone: (301) 451-2020
Fax: (301) 402-0528
Email: dfe@nei.nih.gov

Resource Centers


Co-Chairman
Michael X. Repka, M.D.
Wilmer Eye Institute
233 N. Wolfe Street
Baltimore, MD 21287
USA
Telephone: (410) 955-8314
Fax: (410) 955-0809
Email: mrepka@jhmi.edu

Co-Chairman
Jonathan M. Holmes, M.D.
Mayo Clinic
Department of Ophthalmology W7
200 First Street Southwest
Rochester, MN 55905
USA
Telephone: (507) 284-3760
Fax: (507) 284-8566
Email: holmes.jonathan@mayo.edu

Data Coordinating Center
Roy W. Beck, M.D., Pamela S. Moke, M.S.P.H., Nicole M. Boyle, Danielle Chandler, M.S.P.H., Laura Clark, B. Michele Melia, Sc.M., Heidi A. Gillespie, Raymond T. Kraker, M.S.P.H., Christina M. Morales
Jaeb Center for Health Research
15310 Amberly Drive, Suite 350
Tampa, FL 33647
USA
Telephone: (813) 975-8690
Fax: (813) 975-8761
Email: pedig@jaeb.org
URL: http://public.pedig.jaeb.org/

Protocol Chair
Stephen P. Christiansen, M.D.
University of Minnesota Medical School
Minneapolis, MN

Last Updated: 6/7/2007

 

Bookmark or share this page


U. S. Department of Health and Human Services

National Institutes of Health

USA.gov